DexCom

By MobiHealthNews June 9, 2017
Diabetes management is a focus area for a number of digital health companies, and increasingly large medical device companies like Medtronic and Dexcom are turning to smartphone apps and connected devices for their consumer offerings. So it’s no surprise that at the 77th Scientific Sessions of the American Diabetes Association, which start today, there is a significant health tech presence.  We...
By Jonah Comstock June 7, 2017
At long last, Dexcom's Share app, which allows users to view and share data from their G5 continuous glucose monitors, will be available for Android users. The Android app just now received FDA clearance, and the company will roll out the app this month. The launch is a long time coming: iOS users have had access to the app since 2015. “Providing Android users with access to the Dexcom G5 Mobile...
By Jonah Comstock June 5, 2017
As is becoming the trend, the portion of Apple's WWDC conference dedicated to the Apple Watch featured a heavy focus on the watch's health and fitness features, which continue to be the wearable's hallmark feature set.  "Apple Watch is designed to help you live a healthier life," CEO Tim Cook said, "and people are absolutely loving the fitness capabilities, the health capabilities, the quick...
By Heather Mack June 1, 2017
Digital diabetes management company Glooko and device maker Dexcom have expanded their partnership, effectively creating on-demand access to continuous glucose monitor data for both physicians and patients who use the two companies’ products. Glooko and Dexcom began working together in June 2015, when Glooko first began integrating CGMs and insulin pumps into its platform. But for the past two...
By Jonah Comstock March 24, 2017
In January, the Centers for Medicare and Medicaid Services announced that it would cover continuous glucose monitoring for the first time; specifically it would cover therapeutic CGMs, of which the only one currently recognized is the Dexcom G5. That coverage officially kicks in today, now that CMS has issued the billing codes providers can use to get reimbursed. “This is a new era and a huge win...
By Jonah Comstock March 1, 2017
After the latest in a series of successful quarters (with $171.2 million in revenue, up 31 percent year over year), DexCom is queuing up some big product launches. On yesterday’s Q4 earnings call, CEO Kevin Sayer provided more detail about the forthcoming G6 continuous glucose monitor as well as the first products to come out of DexCom’s partnership with Verily. “In a year of much confusion and...
By Jonah Comstock March 1, 2017
Sharecare has hired two new executives with impressive credentials: John Solomon, who formerly served as vice president of enterprise and government at Apple, will join the company in a strategic advisory role and Dale Rayman, a 27-year Towers Watson vet who also served as chief actuary at Zipongo, will join Sharecare as SVP of actuarial consulting and business development. “John’s proven...
By MobiHealthNews February 17, 2017
This week in Paris, companies in the diabetes managment space came together at the Advanced Technologies and Treatments for Diabetes conference to share news and, mostly, a lot of efficacy data. It's an exciting time for the space as closed-loop systems that allow people with diabetes to monitor their glucose continuously and automatically manage their insulin dosing get closer and closer to...
By Jonah Comstock February 12, 2017
More than two years ago, when Apple first added a list of diabetes management apps to its app store, we covered the list of 13 top picks. A lot can change in a few years, however. And while a few of those same apps still appear on Apple’s current list of 12 diabetes management apps, there’s plenty of new names — though not all new to MobiHealthNews readers — as well. Read on for Apple’s current...
By Jonah Comstock February 9, 2017
The National Institute of Diabetes and Digestive and Kidney Diseases, a part of the National Institutes of Health, has given out $41 milion in grants to four studies that will hopefully make the artificial pancreas – a long-sought, fully automated, closed-loop system for insulin regulation – a reality. Two of the studies are underway and two more are slotted to begin recruiting in the next two...